Changes of leukocyte subsets in coronary artery bypass surgery: Cardiopulmonary bypass versus 'off-pump' techniques

Thoracic and Cardiovascular Surgeon

Volumn 46, Issue 6, 1998, Pages 327-332

  Diegeler, A ^a,b   Tarnok A ^a   Rauch, Th ^a   Haberer, D ^a   Folk, V ^a   Battellini, R ^a   Autschbach, R ^a   Hambsch, J ^a   Schneider, P ^a   Mohr, F W ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

Cardiopulmonary bypass; Coronary artery bypass surgery; Immune respons; Leukocyte subsets

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CORONARY ARTERY BYPASS SURGERY; FEMALE; HUMAN; IMMUNE RESPONSE; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MALE; PATIENT SELECTION; PRIORITY JOURNAL; REPERFUSION; SURGICAL TECHNIQUE; T LYMPHOCYTE SUBPOPULATION;

EID: 0032425287     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1010247     Document Type: Article

References (20)

1. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845-57.
2. Royston D, Minty BD, Higenbottam TW, Wallwork J, Jones GJ. The effects of surgery with cardiopulmonary bypass on alveolar capillary barrier function in man. Ann Thorac Surg. 1993;55:625-30.
3. Wan S, LeClerc JL, Vincent JL Cytokine response to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg. 1997;63:269-76.
4. Rinder CS, Mathew JP, Rinder H, Tracey JB, Davis E, Smith BR. Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender. J Lab Clin Med. 1997;129 (6):592-602.
5. Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichart B. Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunmodulation. J Thorac Cardiovasc Surg. 1993;105:15-24.
6. Lawrence J. T-cell subsets in health, infectious disease, and idiopathic CD4+T lymphocytopenia. Am Intern Med. 1993;119:55-62.
7. Hershman MJ, Cheadle WG, Wellhausen SR, et al. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patients. Br J Surg. 1990;77:204-7.
8. Diegeler A, Falk V, Walther Th, Mohr FW. Minimally invasive coronary artery bypass without extracorporeal circulation. N Engl J Med. 1997;336:1454-55.
9. Calafiore AM, Gianmarco G Di, Teodori G, et al. Left anterior descending coronary artery grafting via left anterior small thoracotomy without cardiopulmonary bypass. Ann Thorac Surg. 1996;61:1658-65.
10. Subramanian VA, Sani G, Benetti FJ, Calafiore AM. Minimally invasive coronary bypass surgery: a multi-center report of preliminary experience. Circulation. 1995;92 Suppl 1:645.
11. Benetti FJ, Naselli G, Wood M, Geffner L. Direct myocardial revascularization without extracorporeal circulation. Experience in 700 patients. Chest. 1991;100:312-16.
12. Cavarocchi NC, Pluth JR, Schaff HV, et al. Complement activation during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1986;91:252-8.
13. Ide H, Kakiuchi T, Furuta N, et al. The effect of cardiopulmonary bypass on T-cells and their subpopulations. Ann Thorac Surg. 1987;44:277-82.
14. Pertillä J, Salo M, Pirtikangas CO, Jalonen J, Vainio O. Effects of cardiopulmonary bypass on lymphocytes and their subset counts with or without use of autotransfusion devices. J Cardiothorac Anesth. 1994;8:532-5.
15. Markewitz A, Faist E, Lang S, Hültner L, Weinhold C, Reichart B. An imbalance in T-helper cell subsets alters immune response after cardiac surgery. Eur J Cardiothorac Surg. 1996;10:61-7.
16. Tajima K, Yamamoto F, Kawazone K, et al. Cardiopulmonary bypass and cellular immunity: changes in lymphocyte subsets and natural killer cell activity. Ann Thorac Surg. 1993;55:625-30.
17. Misoph M, Babin-Ebel J, Schwender S, Grossmann R, Keller F, Elert O. Response of the cellular immune system to cardiopulmonary bypass in vivo. Thorac Cardiovasc Surg. 1997;45:217-23.
18. Butler J. Rocker GM, Westaby S. Inflammatory response to cardioplegic solutions: evaluation by tissue cultures. Ann Thorac Surg. 1993;55:552-9.
19. Carpentier S, Murawsky M, Carpentier A. Cytotoxicity of cardioplegic solutions: evaluation by tissue culture. Circulation. 1981;64(II):90-5.
20. Soeprwata R, Hartman AR, Frerichmann V, Stefano G, Scheid HH, Bilfinger TV. Apotinin diminishes inflammatory response. Int J Card. 1996;53 (suppl):55-63.